Rp-Adenosine 3′,5′-cyclic Monophosphorothioate, Sodium Salt (Rp-cAMP), a membrane permeable compound, is shown to be an an inhibitor of PKA (cAMP-dependent). This compound displays a capacity to inhibit dbcAMP- and Sp-cAMPS (sc -201571)-induced stimulation of bone resorption in mice. Furthermore, due to its effects on cAMP, Rp-cAMP can also inhibit cAMP mediated cell growth of certain cells. Other effects of PKA activation inhibition noted include a decrease in glucagon-induced glycogenolysis in hepatocytes isolated from fed rats.
1. Rothermel, J.D., et al. 1984. J. Biol. Chem. 259: 8151-8155. PMID: 6330102
2. Wang, L.Y., et al. 1991. Science. 253: 1132-1135. PMID: 1653455
3. Kaji, H., et al. 1992. Biochem. Biophys. Res. Commun. 182: 1356-1361. PMID: 1311571
4. Yokozaki, H., et al. 1992. Cancer Res. 52: 2504-2508. PMID: 1314695
See how others have used Rp-Adenosine 3prime,5prime-cyclic Monophosphorothioate, Sodium Salt (CAS 73208-40-9). Click on the entry to view the PubMed entry .
PMID: # 22871966 Adriana R. Rodrigues et al. 2012. Mol. Endoc. 361: 69-79.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.